RE: Turnaround.2 Aug 2021 15:00
We got phase II and phase III trials going on and results are due in oct.
As NICKE said earlier,look at the sng doing trial,whose mcap is 300m!!
While we are already generating revenues and phaseIII trial results are due soon,we will see significant RERATE here!
All those costs mentioned are R&D and manufacturing costs,plus staff costs and directors remuneration are common in all companies. So stop scaremongering here. We all knows what is coming here including you and this is not the only company who spending those numbers in trials!! Do more research mate.